Sprint Bioscience AB (publ) (FRA:5JA1)

Sprint Bioscience AB Statistics

Total Valuation

FRA:5JA1 has a market cap or net worth of EUR 21.84 million. The enterprise value is 9.97 million.

Market Cap	21.84M
Enterprise Value	9.97M

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	105.52M
Shares Outstanding	n/a
Shares Change (YoY)	+32.63%
Shares Change (QoQ)	+1.19%
Owned by Insiders (%)	23.68%
Owned by Institutions (%)	12.04%
Float	70.62M

Valuation Ratios

The trailing PE ratio is 2.58 and the forward PE ratio is 12.02.

PE Ratio	2.58
Forward PE	12.02
PS Ratio	1.41
PB Ratio	1.98
P/TBV Ratio	1.98
P/FCF Ratio	2.83
P/OCF Ratio	2.83
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.08, with an EV/FCF ratio of 1.29.

EV / Earnings	1.18
EV / Sales	0.64
EV / EBITDA	1.08
EV / EBIT	1.09
EV / FCF	1.29

Financial Position

The company has a current ratio of 7.60

Current Ratio	7.60
Quick Ratio	7.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	15.67

Financial Efficiency

Return on equity (ROE) is 142.84% and return on invested capital (ROIC) is 94.68%.

Return on Equity (ROE)	142.84%
Return on Assets (ROA)	68.05%
Return on Invested Capital (ROIC)	94.68%
Return on Capital Employed (ROCE)	81.64%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	532,648
Profits Per Employee	292,299
Employee Count	29
Asset Turnover	1.87
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +63.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+63.75%
50-Day Moving Average	0.13
200-Day Moving Average	0.06
Relative Strength Index (RSI)	67.10
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:5JA1 had revenue of EUR 15.45 million and earned 8.48 million in profits. Earnings per share was 0.09.

Revenue	15.45M
Gross Profit	14.24M
Operating Income	8.99M
Pretax Income	8.48M
Net Income	8.48M
EBITDA	9.09M
EBIT	8.99M
Earnings Per Share (EPS)	0.09

Balance Sheet

The company has 11.71 million in cash and n/a in debt, with a net cash position of 11.71 million.

Cash & Cash Equivalents	11.71M
Total Debt	n/a
Net Cash	11.71M
Net Cash Per Share	n/a
Equity (Book Value)	11.01M
Book Value Per Share	0.10
Working Capital	10.66M

Cash Flow

In the last 12 months, operating cash flow was 7.72 million and capital expenditures -8,686, giving a free cash flow of 7.71 million.

Operating Cash Flow	7.72M
Capital Expenditures	-8,686
Free Cash Flow	7.71M
FCF Per Share	n/a

Margins

Gross margin is 92.18%, with operating and profit margins of 58.20% and 54.88%.

Gross Margin	92.18%
Operating Margin	58.20%
Pretax Margin	54.88%
Profit Margin	54.88%
EBITDA Margin	58.84%
EBIT Margin	58.20%
FCF Margin	49.91%

Dividends & Yields

FRA:5JA1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.63%
Shareholder Yield	-32.63%
Earnings Yield	38.82%
FCF Yield	35.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:5JA1 has an Altman Z-Score of 5.38 and a Piotroski F-Score of 6.

Altman Z-Score	5.38
Piotroski F-Score	6